Home
About Us
Information & Guidelines
Article Processing Charges
Open Access Policy
Terms and Conditions
Privacy Policy
Information For Authors
Information Editorial Board
Contact Us
FAQ
Paper Submission Guideline
Register
Login
Submit Now
Vol - 28, Issue - 07
Full-Text PDF
About the Journal
Download
[This article belongs to Volume - 28, Issue - 07]
International Medical Journal
Journal ID
:
IMJ-05-08-2021-827
Total View
:
350
Title
:
TREATMENT WITH REMDESIVIR IN PATIENTS WITH COVID19 EXPERIENCE IN THE REPUBLIC OF KAZAKHSTAN
Abstract
: As of June 26, 2021, there were 181 million patients with coronavirus 2019 (COVID-19) worldwide, of whom more than 3.9 million had died (https://coronavirus-monitor.info). Currently, there is an increase in the incidence of coronavirus infection in Kazakhstan in almost all regions due to a new highly contagious variant of COVID-19, Delta. According to statistics as of June 26, 2021, 414,712 Kazakhstani people fell ill, of whom 4,281 died (https://coronavirus-monitor.info/country/kazakhstan/).
Download Info
×
Paper Access Key
Access Key
Submit
No Access Key (
Request for Download
)
Name
Email
Country
Send Request
Our Certificates
Guidelines
Information For Authors
Information Editorial Board
FAQ
Further Information
Article Processing Charges
Open Access Policy
Terms and Conditions
Privacy Policy
//